Placental Infection Associated with SARS-CoV-2 Wildtype Variant and Variants of Concern.

SARS-CoV-2 SARS-CoV-2 variants of concern pregnancy waves of COVID-19

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
13 Sep 2023
Historique:
received: 11 08 2023
revised: 04 09 2023
accepted: 09 09 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

The original SARS-CoV-2 lineages have been replaced by successive variants of concern (VOCs) over time. The aim of this study was to perform an assessment of the placental infection by SARS-CoV-2 according to the predominant variant at the moment of COVID-19 diagnosis. This was a prospective study of SARS-CoV-2-positive pregnant women between March 2020 and March 2022. The population was divided into pregnancies affected by COVID-19 disease during 2020 (Pre-VOC group) and pregnancies affected after December 2020 by SARS-CoV-2 variants of concern (VOC group). The presence of virus was assessed by RT-PCR, and the viral variant was determined by whole genome sequencing. A total of 104 placentas were examined, among which 54 cases belonged to the Pre-VOC group and 50 cases belonged to the VOC group. Sixteen positive placental RT-PCR tests for SARS-CoV-2 were reported. The NGS analysis confirmed the SARS-CoV-2 lineage in placenta tissue. All samples corresponded to the Pre-VOC group, whereas no placental presence of SARS-CoV-2 was detected in the VOC group (16, 29.6% vs. 0, 0.0%

Identifiants

pubmed: 37766324
pii: v15091918
doi: 10.3390/v15091918
pmc: PMC10536606
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : FEDER ("Una manera de hacer Europa, Construyendo Europa desde Aragón"/European Social Funds)
ID : 277B05_17D
Organisme : Government of Aragon
ID : (LMP228_21 (2022-2023))

Références

Nat Commun. 2022 Jan 18;13(1):320
pubmed: 35042863
Arch Pathol Lab Med. 2021 May 1;145(5):517-528
pubmed: 33393592
Obstet Gynecol. 2022 Aug 1;140(2):262-265
pubmed: 35852277
Histopathology. 2020 Dec;77(6):994-999
pubmed: 32692408
Lancet. 2022 Apr 23;399(10335):1618-1624
pubmed: 35397851
Viruses. 2022 Nov 27;14(12):
pubmed: 36560652
Ultrasound Obstet Gynecol. 2022 Jun;59(6):813-822
pubmed: 35353936
Nat Rev Immunol. 2017 Aug;17(8):469-482
pubmed: 28627518
J Infect Chemother. 2023 Jan;29(1):33-38
pubmed: 36103949
Vaccines (Basel). 2022 Dec 17;10(12):
pubmed: 36560582
Eur J Obstet Gynecol Reprod Biol. 2008 Jan;136(1):20-4
pubmed: 17287065
Placenta. 2022 Jan;117:47-56
pubmed: 34768168
Nat Commun. 2020 Oct 12;11(1):5128
pubmed: 33046695
Obstet Gynecol. 2020 Aug;136(2):252-258
pubmed: 32433453
Ultrasound Obstet Gynecol. 2022 Dec;60(6):814-816
pubmed: 35809244
Am J Reprod Immunol. 2015 Mar;73(3):199-213
pubmed: 25582523
Am J Surg Pathol. 2022 Jan 1;46(1):51-57
pubmed: 34310367
BMJ Med. 2022 Feb 28;1(1):e000053
pubmed: 36936566
J Infect Dis. 2023 Feb 1;227(3):344-352
pubmed: 36214810
Am J Obstet Gynecol. 2021 Sep;225(3):289.e1-289.e17
pubmed: 34187688
Int J Surg Pathol. 2023 Jun;31(4):387-397
pubmed: 35645148
Lancet. 2023 Feb 11;401(10375):447-457
pubmed: 36669520
Fetal Diagn Ther. 2021;48(11-12):801-811
pubmed: 34794139
N Engl J Med. 2014 Jun 5;370(23):2211-8
pubmed: 24897084
Viruses. 2023 Aug 05;15(8):
pubmed: 37632041
Placenta. 2020 Oct;100:69-74
pubmed: 32862058
Semin Perinatol. 2009 Jun;33(3):130-7
pubmed: 19464502
J Clin Invest. 2021 Mar 15;131(6):
pubmed: 33497369
Placenta. 2023 Jul;138:88-96
pubmed: 37235921
Nature. 2022 Feb;602(7898):657-663
pubmed: 35016194
Lancet Respir Med. 2022 Dec;10(12):1129-1136
pubmed: 36216011
Am J Obstet Gynecol. 2021 Jan;224(1):35-53.e3
pubmed: 32739398
Am J Obstet Gynecol. 2022 Feb;226(2):236.e1-236.e14
pubmed: 34389291
Pregnancy Hypertens. 2022 Mar;27:148-169
pubmed: 35066406
Front Med (Lausanne). 2021 May 04;8:653516
pubmed: 34017846
J Perinat Med. 2023 Feb 17;51(7):823-839
pubmed: 36800343
Nat Rev Immunol. 2022 May;22(5):277-282
pubmed: 35304596
Hum Pathol. 2022 Mar;121:46-55
pubmed: 34995674
Clin Microbiol Infect. 2022 Feb;28(2):202-221
pubmed: 34715347
J Microbiol Immunol Infect. 2021 Feb;54(1):12-16
pubmed: 32425996
JAMA Pediatr. 2021 Aug 1;175(8):817-826
pubmed: 33885740
Viruses. 2022 Mar 14;14(3):
pubmed: 35337011
iScience. 2022 May 20;25(5):104223
pubmed: 35434541
Am J Obstet Gynecol. 2022 Jan;226(1):149-151
pubmed: 34529957

Auteurs

Ana Medel-Martinez (A)

Instituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, Spain.
Placental Pathophysiology & Fetal Programming Research Group, B46_20R & GIIS-028 del IISA, 50009 Zaragoza, Spain.

Cristina Paules (C)

Instituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, Spain.
Placental Pathophysiology & Fetal Programming Research Group, B46_20R & GIIS-028 del IISA, 50009 Zaragoza, Spain.
Obstetrics Department, Hospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, Spain.
Red RICORS "Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin", RD21/0012/0001, Instituto de Salud Carlos III, 28029 Madrid, Spain.

María Peran (M)

Instituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, Spain.
Placental Pathophysiology & Fetal Programming Research Group, B46_20R & GIIS-028 del IISA, 50009 Zaragoza, Spain.
Biochemistry Department, Hospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, Spain.

Pilar Calvo (P)

Instituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, Spain.
Placental Pathophysiology & Fetal Programming Research Group, B46_20R & GIIS-028 del IISA, 50009 Zaragoza, Spain.
Obstetrics Department, Hospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, Spain.

Sara Ruiz-Martinez (S)

Instituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, Spain.
Placental Pathophysiology & Fetal Programming Research Group, B46_20R & GIIS-028 del IISA, 50009 Zaragoza, Spain.
Obstetrics Department, Hospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, Spain.
Red RICORS "Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin", RD21/0012/0001, Instituto de Salud Carlos III, 28029 Madrid, Spain.

María Ormazabal Cundin (M)

Instituto Aragonés de Ciencias de la Salud (IACS), Centro de Investigación Biomédica de Aragón (CIBA), 50009 Zaragoza, Spain.

Alberto Cebollada-Solanas (A)

Instituto Aragonés de Ciencias de la Salud (IACS), Centro de Investigación Biomédica de Aragón (CIBA), 50009 Zaragoza, Spain.

Mark Strunk (M)

Instituto Aragonés de Ciencias de la Salud (IACS), Centro de Investigación Biomédica de Aragón (CIBA), 50009 Zaragoza, Spain.

Jon Schoorlemmer (J)

Placental Pathophysiology & Fetal Programming Research Group, B46_20R & GIIS-028 del IISA, 50009 Zaragoza, Spain.
Instituto Aragonés de Ciencias de la Salud (IACS), Centro de Investigación Biomédica de Aragón (CIBA), 50009 Zaragoza, Spain.
ARAID Foundation, 50009 Zaragoza, Spain.

Daniel Oros (D)

Instituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, Spain.
Placental Pathophysiology & Fetal Programming Research Group, B46_20R & GIIS-028 del IISA, 50009 Zaragoza, Spain.
Obstetrics Department, Hospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, Spain.
Red RICORS "Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin", RD21/0012/0001, Instituto de Salud Carlos III, 28029 Madrid, Spain.

Marta Fabre (M)

Instituto de Investigación Sanitario de Aragón (IIS Aragon), 50009 Zaragoza, Spain.
Placental Pathophysiology & Fetal Programming Research Group, B46_20R & GIIS-028 del IISA, 50009 Zaragoza, Spain.
Red RICORS "Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin", RD21/0012/0001, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Biochemistry Department, Hospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, Spain.

Classifications MeSH